A detailed history of Stonepine Capital Management, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 1,369,821 shares of EOLS stock, worth $14.9 Million. This represents 14.02% of its overall portfolio holdings.

Number of Shares
1,369,821
Previous 1,657,611 17.36%
Holding current value
$14.9 Million
Previous $18 Billion 23.39%
% of portfolio
14.02%
Previous 16.41%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$10.66 - $17.48 $3.07 Million - $5.03 Million
-287,790 Reduced 17.36%
1,369,821 $22.2 Billion
Q2 2024

Aug 13, 2024

SELL
$10.45 - $13.76 $10.6 Million - $14 Million
-1,016,745 Reduced 38.02%
1,657,611 $18 Billion
Q1 2024

May 14, 2024

SELL
$9.99 - $14.91 $26.6 Million - $39.6 Million
-2,658,648 Reduced 49.85%
2,674,356 $37.4 Billion
Q4 2023

Feb 13, 2024

BUY
$7.6 - $10.53 $1.17 Million - $1.62 Million
154,000 Added 2.97%
5,333,004 $56.2 Billion
Q3 2023

Nov 13, 2023

BUY
$7.15 - $10.2 $37 Million - $52.8 Million
5,179,004 New
5,179,004 $47.3 Billion
Q2 2023

Aug 11, 2023

BUY
$7.23 - $10.52 $28.4 Million - $41.3 Million
3,927,402 Added 678.55%
4,506,197 $32.8 Million
Q1 2023

May 12, 2023

SELL
$7.81 - $11.05 $2 Million - $2.82 Million
-255,637 Reduced 30.64%
578,795 $4.9 Million
Q4 2022

Feb 14, 2023

BUY
$6.52 - $8.95 $4.14 Million - $5.68 Million
634,432 Added 317.22%
834,432 $6.27 Million
Q3 2022

Nov 10, 2022

BUY
$7.76 - $13.72 $1.55 Million - $2.74 Million
200,000 New
200,000 $1.61 Million
Q2 2022

Aug 12, 2022

SELL
$10.22 - $13.94 $5.99 Million - $8.17 Million
-586,224 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.22 - $11.78 $6.67 Million - $15 Million
-1,276,872 Reduced 68.53%
586,224 $6.58 Million
Q4 2021

Feb 14, 2022

BUY
$5.37 - $8.38 $8.39 Million - $13.1 Million
1,563,096 Added 521.03%
1,863,096 $12.1 Million
Q3 2021

Nov 12, 2021

BUY
$7.36 - $13.67 $2.21 Million - $4.1 Million
300,000 New
300,000 $2.29 Million
Q2 2020

Aug 13, 2020

SELL
$3.53 - $6.17 $2.91 Million - $5.08 Million
-822,960 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$3.53 - $12.21 $1.51 Million - $5.23 Million
428,070 Added 108.4%
822,960 $3.42 Million
Q4 2019

Feb 13, 2020

BUY
$11.58 - $17.37 $4.57 Million - $6.86 Million
394,890 New
394,890 $4.81 Million
Q2 2018

Aug 14, 2018

SELL
$6.85 - $38.49 $405,718 - $2.28 Million
-59,229 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$8.34 - $12.5 $493,969 - $740,362
59,229 New
59,229 $535,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $611M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.